Deep Genomics and BioMarin are collaborating to discover and develop oligonucleotide drug candidates for four rare diseases
Read More
Round led by Future Ventures and received investments from Amplitude Ventures, Khosla Ventures, Magnetic Ventures, True Ventures and NJF Capital
Read More